Related Experiment Video
Updated: Mar 2, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.2K
Atrial Fibrillation and Renal Disease
Alexander Berkowitsch1, Maciej Wójcik2, Sergey Zaltsberg1
1Kerckhoff Heart Center, Bad Nauheim, Germany.
Journal of Atrial Fibrillation
|May 13, 2017
Summary
Atrial fibrillation (AF) and kidney disease often occur together. This paper discusses balancing stroke prevention with bleeding risks during anticoagulation and the challenges of catheter ablation for AF patients with kidney dysfunction.
Area of Science:
- Cardiology
- Nephrology
- Clinical Medicine
Background:
- Atrial fibrillation (AF) and renal dysfunction are frequently observed comorbidities in the general population.
- Managing anticoagulation in AF patients with kidney disease presents a significant clinical challenge.
- Catheter ablation for AF in patients with renal dysfunction requires careful consideration.
Purpose of the Study:
- To discuss optimal anticoagulation strategies for patients with both atrial fibrillation and renal dysfunction.
- To review the considerations and challenges associated with catheter ablation in this patient group.
Main Methods:
- Literature review and discussion of existing epidemiological data.
- Analysis of the risks and benefits of anticoagulation therapies.
- Examination of the safety and efficacy of catheter ablation procedures.
Main Results:
- Balancing the risk of ischemic stroke against the risk of hemorrhage is crucial for anticoagulation.
- Catheter ablation in patients with renal dysfunction requires tailored approaches.
- Further research is needed to optimize management strategies.
Conclusions:
- Optimal anticoagulation and catheter ablation require individualized treatment plans for AF patients with renal dysfunction.
- Effective management necessitates a multidisciplinary approach considering both cardiac and renal health.
More Related Videos
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
528
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
528
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
01:22Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
01:11Renal Failure: Dose Adjustments
537
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
537
01:23Rheumatic Heart Disease I: Introduction
656
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
656
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K